Home › Blood Cancers › Illinois › Cicero
Blood Cancers clinical trials in Cicero, IL
5 studies for Blood Cancers are looking for participants at sites in and around Cicero (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- OSF Little Company of Mary Medical Center, Evergreen Park · 9 mi away
- Advocate Christ Medical Center, Oak Lawn · 9 mi away
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
RecruitingObservational study
- Loyola University Medical Center, Maywood · 5 mi away
- Advocate Christ Medical Center, Oak Lawn · 9 mi away
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RecruitingPhase 1
- Loyola University Medical Center, Maywood · 5 mi away
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
- Loyola University Medical Center, Maywood · 5 mi away
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RecruitingPhase 1
- Loyola University Medical Center, Maywood · 5 mi away
Blood Cancers trials in other cities
- Houston, TX46 studies
- New York City, NY26 studies
- Boston, MA25 studies
- Washington, DC19 studies
- Baltimore, MD18 studies
- Seattle, WA18 studies
- Los Angeles, CA17 studies
- Durham, NC16 studies
- Chicago, IL15 studies
- Philadelphia, PA14 studies
- Atlanta, GA13 studies
- Nashville, TN13 studies
Other studies in Cicero
- Non-Small Cell Lung Cancer24 studies
- Lung Cancer17 studies
- Prostate Cancer14 studies
- Cancer (all types)13 studies
- Acute Myeloid Leukemia11 studies
- Breast Cancer11 studies
- Colorectal Cancer10 studies
- Bladder Cancer8 studies
- Metastatic Cancer7 studies
- Melanoma7 studies
- Cardiovascular Disease7 studies
- Burkitt Lymphoma6 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.